Reconnecting Practicing Hygienists with the Nation's Leading Educators and Researchers.

The Warning Signs of Blood Disorders Hiding in the Mouth

Explore the oral manifestations of immune thrombocytopenia, autoimmune hemolytic anemia, and Evans syndrome, along with strategies for identifying concerning findings, modifying dental hygiene care, and minimizing bleeding risks.

While interconnected autoimmune blood disorders may be rare, they often show their first signs in the dental operatory. With symptoms ranging from increased risk of mucosal bleeding to anemia, fatigue, and jaundice, early detection of these diseases will help patients receive the treatment they need.

Immune thrombocytopenia (ITP), autoimmune hemolytic anemia (AIHA), and Evans syndrome all present oral findings that may present before a patient ever gets a hematologic diagnosis and the dental hygienist is usually the first one to notice. That’s not a small number: 30% to 40% of blood disorders turn up in the mouth first before any other diagnosis is on the table.1,2 Patients on anticoagulant or antiplatelet therapy present with overlapping concerns, so much of what follows also applies to that population. Most dental hygienists will see some of these patients over their career, therefore they need to be up to date on these disorders.

Medical History and Threshold Awareness

Dental hygienists are well versed in taking careful medical and medication histories at each appointment. If a patient discloses a bleeding disorder or anticoagulant use, his or her physician or hematologist should be contacted for medical clearance before beginning an invasive procedure. Their current platelet count and overall bleeding risk should be noted. If the count is below 50,000/µL, most clinicians will defer elective periodontal instrumentation; although the exact cutoff is a clinical judgment, this is a widely used benchmark, not a hard rule.3,4

White cell status is important in patients on immunosuppressive drugs. A neutrophil count under 500/µL means severe neutropenia; these patients are genuinely at risk for infection from oral bacteria.5 Whether prophylactic antibiotics are indicated depends on the specifics, such as drug regimen, degree of neutropenia, and treatment plan, so the patient’s medical team must be consulted.

Before starting a procedure, the patient should rinse with an antimicrobial. This is a quick, low-stakes way to cut the bacterial load.6,7 Skip anything with alcohol, which can irritate mucosa that’s already fragile or hemorrhage prone.

Recognizing the Signs

Start with a thorough soft-tissue exam before beginning scaling. Petechiae, tiny nonblanching red or purple pinpoints under 2 mm, tend to cluster on the soft palate, buccal mucosa, and lateral tongue.8 When platelet counts continue to drop, those spots can spread and coalesce into larger ecchymotic patches. A patient with Evans syndrome may also come in with unusually pale oral tissues or a smooth, depapillated tongue (atrophic glossitis) from the hemolytic anemia component affecting tissue oxygenation.

The sign that should alert clinicians is gingival bleeding with no good explanation for it. Healthy gingival tissue bleeds because something mechanical provoked it: a probe, a scaler, a toothbrush. Gingival tissue bleeding with almost no plaque, before treatment has begun? It should be treated like ITP until a physician says otherwise.9 Treatment should be ceased, findings documented, and patient should be referred to a primary care provider for evaluation.

Modifying Technique

Once the patient has been cleared for treatment, the approach should be deliberate. Ultrasonic instrumentation with light, controlled strokes tends to be gentler on inflamed tissue than heavy handed scaling, and it’s more efficient when bleeding risk is possible.10

Don’t try to do everything at once. Treating one quadrant or sextant per appointment limits how much tissue is disrupted, which also limits the hemostatic demand. The same goes for a suction tip. The floor of the mouth and buccal tissue are easy to traumatize so avoid letting the tip linger or dig in.

Local Anesthesia Considerations

An inferior alveolar nerve block is risky on a patient with a significant bleeding disorder. This injection penetrates a vascular anatomical space, and a hematoma from inadvertent vessel injury, while uncommon, can expand into deep fascial planes and, in serious cases, threaten the airway.11

Buccal infiltration and periodontal ligament injections are worth considering as alternatives. Both keep the needle out of those deep spaces and still provide adequate anesthesia for most dental hygiene procedures.11,12 An anesthesia plan should be created with the dentist in anticipation of the appointment.

Hemostasis and Post-Appointment Care

Before the patient leaves the chair, confirm that there is hemostasis at every instrumented site. If there is persistent sulcular oozing, apply firm direct pressure with gauze for a few minutes. Topical tranexamic acid, if it’s been prescribed, is a useful adjunct; it stabilizes the fibrin clot by blocking fibrinolysis without touching systemic coagulation.13,14

Send the patient home with clear instructions: soft foods, no hard rinsing, gentle brushing only, and refrain from flossing the treated sites for 48 hours.

The Bigger Picture

Many patients with ITP or Evans syndrome quietly stop brushing and flossing because they’re afraid of bleeding. That’s understandable, but the inflammation that builds up from neglected periodontal health doesn’t stay local. It sends cytokines and bacterial products into circulation — right into a systemic environment that’s already fighting itself over platelets and red cells.15,16

Maintaining gingival health in these patients goes beyond routine oral hygiene; it is an essential component of disease management.

References

  1. Barros P, Islam MN, Fitzpatrick SG, Cohen DM, Bhattacharyya I, Alramadhan SA. Essentials of oral manifestations of leukemia for the dental practitioner. Gen Dent. 2022;70:33-36.
  2. Quispe RA, Aguiar EM, de Oliveira CT, Neves ACX, Santos PSDS. Oral manifestations of leukemia as part of early diagnosis. Hematol Transfus Cell Ther. 2022;44:392-401.
  3. van Dijk WEM, van Es RJJ, Correa MEP, Schutgens REG, van Galen KPM. Dentoalveolar procedures in immune thrombocytopenia; systematic review and an institutional guideline. TH Open. 2021;5:e489-e502.
  4. Provan D, Arnold DM, Bussel JB, et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia. Blood Adv. 2019;3:3780-3817.
  5. Diz-Dios P, Ocampo-Hermida A, Fernandez-Feijoo J. Quantitative and functional neutrophil deficiencies. Med Oral. 2002;7:206-221.
  6. Gupta G, Mitra D, Ashok KP, et al. Efficacy of preprocedural mouth rinsing in reducing aerosol contamination produced by ultrasonic scaler: a pilot study. J Periodontol. 2014;85:562-568.
  7. Devker NR, Mohitey J, Vibhute A, et al. A comparative evaluation of the efficacy of preprocedural mouthrinsing and high volume evacuator attachment alone and in combination in reducing the amount of viable aerosols produced during ultrasonic scaling procedure. J Contemp Dent Pract. 2012;13:681-689.
  8. Vaisman B, Medina AC, Ramirez G. Dental treatment in children with haematological disease: retrospective study. Int J Paediatr Dent. 2004;14:355-362.
  9. Santos LOTD, Santos AS, Oliveira MS, et al. Primary immune thrombocytopenic purpura with exuberant oral manifestations in a patient with Turner syndrome. Spec Care Dentist. 2024;44:1564-1571.
  10. Toygar HU, Guzeldemir E. Excessive gingival bleeding in two patients with Glanzmann thrombasthenia. J Periodontol. 2007;78:1154-8.
  11. Anderson JAM, Brewer A, Creagh D, et al. Guidance on the dental management of patients with haemophilia and congenital bleeding disorders. Br Dent J. 2013;215:497-504.
  12. Kämmerer PW, Adubae A, Buttchereit I, et al. Prospective clinical study comparing intraligamentary anesthesia and inferior alveolar nerve block for extraction of posterior mandibular teeth. Clin Oral Investig. 2018;22:1469-1475.
  13. Zaib A, Shaheryar M, Shakil M, et al. Local tranexamic acid for preventing hemorrhage in anticoagulated patients undergoing dental and minor oral procedures: a systematic review and meta-analysis. Healthcare (Basel). 2022;10:2523.
  14. Carter G, Goss A. Tranexamic acid mouthwash — a prospective randomized study of a 2-day regimen vs 5-day regimen to prevent postoperative bleeding in anticoagulated patients requiring dental extractions. Int J Oral Maxillofac Surg. 2003;32:504-507.
  15. Hajishengallis G, Chavakis T. Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities. Nat Rev Immunol. 2021;21:426-440.
  16. Tonetti MS, Van Dyke TE; working group 1 of the joint EFP/AAP workshop. Periodontitis and atherosclerotic cardiovascular disease: consensus report of the Joint EFP/AAP Workshop on Periodontitis and Systemic Diseases. J Clin Periodontol. 2013;40(Suppl 14):S24-9.

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

SAVE BIG ON CE BEFORE 2026!

Coupon has expired

Promotional Period: 12/13/25 – 12/31/25

Get Special CE Savings!